Exploring host-virus interaction to improve immunotherapy against Ebola virus.

Kasumba, Dacquin M; Misasi, John; Mulangu, Sabue; Mbala-Kingebeni, Placide

Kasumba, Dacquin M; Misasi, John; Mulangu, Sabue; Mbala-Kingebeni, Placide.

Afiliação

Kasumba DM; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Axis of Molecular Immunology and Pathogenesis, Molecular Biology Unit, Department of Basic Sciences, Faculty of Medicine, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo. Electronic address: da
Misasi J; National Institutes of Health, National Institute of Allergy and Infectious Diseases, Vaccine Research Center, Bethesda, MD 20892, USA. Electronic address: john.misasi@nih.gov.
Mulangu S; Global Medical Affairs, Ridgeback Biotherapeutics, Miami, FL, USA. Electronic address: sabue@ridgebackbio.com.
Mbala-Kingebeni P; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo. Electronic address: mbalaplacide@gmail.com.

Trends Pharmacol Sci ; 44(12): 857-861, 2023 12.

Article em En | MEDLINE | ID: mdl-37845170

Assuntos

Ebolavirus; Doença pelo Vírus Ebola; Humanos; Doença pelo Vírus Ebola/terapia; Interações entre Hospedeiro e Microrganismos; Imunoterapia

Palavras-chave

Ebola; antibody; immune response; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Ebolavirus Limite: Humans Idioma: En Revista: Trends Pharmacol Sci Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google